MedPath

Negative Oral Contrast Agents Utilization in PET/CT Studies

Conditions
PET/CT
Oral Contrast
Registration Number
NCT04577586
Lead Sponsor
Assiut University
Brief Summary

To compare the performance of different negative oral contrast agents in bowel distension in patient referred for PET/CT studies for various causes aiming for identification of ideal oral contrast agent(OCA).

Detailed Description

Evaluation of gastrointestinal pathology depends on adequate bowel distention, which optimizes resolution of the bowel wall and contents. Traditionally, high-attenuation oral Contrast material in the form of iodine solutions or barium suspensions has been used to obtain bowel distension in MDCT examinations

Traditional high-contrast oral agents like iodine solutions, and barium suspensions which due to overcorrection problems in PET-CT interpretation lowers the accuracy of diagnosis. Negative oral contrast agents like water, air, fat containing agents used with 12.5% corn oil and polyethylene glycol has been used in radiological studies. Milk with 4% fat content has also been tested out in radiological studies and found to be effective. As it is more easily available, palatable, and acceptable especially, by children it needed to be tested in the visualization of the GIT in the PET-CT studies compared to other negative contrast agents.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • all patients referred to our unit for PET/CT study for various causes
Exclusion Criteria
  • Patients with GIT disease.
  • Pregnancy and lactation.
  • Severely ill patients.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
compare the performance of different negative oral contrast agents in PET/Ct studiesbaseline

comparing the effect of different oral contrast on bowel distention

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine

🇪🇬

Assiut, Egypt

Faculty of Medicine
🇪🇬Assiut, Egypt
Nahla Bashank, MD
Contact
01009466255
nahla_bashank_2006@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.